2006 Ed. Geistlich Söhne AG - Alle Rechte vorbehalten
english   deutsch  
About us    News    Contact    Partners/Distributors    Search    Sitemap
Geistlich Group

News

 

23. April 2010 - Awarded: Alufoil Trophy 2010 for Aluminium Template

In April the European Aluminium Foil Association awarded the Alufoil Trophy 2010 to the Aluminium Template for trimming the Chondro-Gide® collagen matrix. The template impressed the independent jury in the Technical Innovation category.

The aluminium template for trimming the Chondro-Gide® collagen matrix won the Alufoil Trophy 2010 in the Technical Innovation category. “This innovative idea should be a boon in surgical techniques,” commented the jury chairman Terry Robins. The European Aluminium Foil Association (EAFA) awards the Alufoil Trophy annually. Geistlich Surgery developed the template in collaboration with the packaging specialists Amcor Flexibles.

Accurate impression of damaged cartilage
Geistlich Surgery now includes the aluminium template in the Chondro-Gide® delivery package. Surgeons use the collagen matrix to treat cartilage damage. Geistlich Surgery developed the innovative aluminium template at the request of surgeons. It enables them to take an accurate impression of damaged cartilage during surgery. The impression serves as a pattern for cutting Chondro-Gide® to fit so that it perfectly covers the cartilage defect.

Pioneering achievement: sole supplier worldwide
With the aluminium template for Chondro-Gide®, Geistlich Surgery has once again done pioneering work: for the first time in history, a manufacturer has developed an aluminium foil for use in open-body operations. Geistlich Surgery is the first and, as yet, the only supplier of this kind of aluminium template. The material had to meet high demands in terms of handling and usage in the sterile operating environment. "Patients' safety has always been paramount during product development," explains Adrian Schnyder, Geistlich Surgery Project Manager.

Leader with focus on regeneration
Chondro-Gide®, the leading matrix made of natural collagen, is used by surgeons in various techniques to treat cartilage damage. In 2006 Geistlich Pharma AG was awarded the Innovation Prize by the Central Swiss Chamber of Commerce for the development of Chondro-Gide® and the AMIC® technique. Geistlich Surgery is one of three business units of Geistlich Pharma AG and specialises in the regeneration of bone and cartilage in orthopaedics and traumatology.

Alu_Trophy_2010__016.jpgProductshot_Chondro-Gide_30x40.jpgTemplate_Sterile.jpgTemplate_Blue.jpg


15th December 2010
50 years – UK subsidiary celebrates its anniversary
Geistlich Sons Limited, the British subsidiary of Geistlich Pharma AG, celebrates its 50th anniversary in 2010 ...
» more

15.11.2010
PRESS RELEASE Dr. Terance Hart – the new Chief Scientific Officer in post for 100 days
The Board of Geistlich Pharma AG has had a full complement since 1st August 2010 with the appointment of Dr. Terance Hart as the Chief Scientific Officer (CSO).
» more

10th October 2010
EAO Conference in Glasgow: a resounding success!
This year's European Association for Osseointegration (EAO) conference took place in Glasgow from 7th – 9th October. As the gold sponsor, Geistlich Biomaterials was represented with a stand ...
» more

22 September 2010
250 days of the Geistlich Biomaterials Business Center at Inibsa!
Geistlich Pharma and Laboratorios Inibsa have been working together in a new structure in Spain for 250 days. An analysis of the first eight months has exceeded expectations.
» more

PRESS RELEASE 1 June 2010
New Brazilian subsidiary extends the Geistlich Pharma family
Geistlich Pharma AG has set up a subsidiary company in Brazil. From now on Geistlich biomaterials will be available directly on the largest South American market.
» more

27 May 2010
First German reference centre for cartilage regeneration named in Bochum
Geistlich Surgery named the Orthopaedic Department of the Catholic University Hospital Bochum (Katholisches Klinikum Bochum) as the first university reference centre for cartilage regeneration in Germany on 26 May...
» more

14 April 2010
Geistlich Pharma wins the 2010 Central Switzerland SVC Entrepreneur Prize
On 14th April Geistlich Pharma AG won the 2010 Central Switzerland Entrepreneur Prize awarded by the Swiss Venture Club (SVC) ...
» more

PRESS RELEASE: 16 March 2010
Geistlich Pharma buys the Walzmühle AG Wolhusen site
A sign of growth and investment in Central Switzerland ...
» more

23 December 2009
The Osteology Foundation grew internationally in 2009
The Osteology Foundation is developing more and more into an international institution in research and education ...
» more

16 December 2009
NEW: Geistlich Pharma at a glance
The new corporate flyer about Geistlich Pharma AG - online now ......
» more

13. Oktober 2009
High visitor numbers to Geistlich Symposium at EAO Congress 09
Geistlich Biomaterials catered for the high numbers attending with top-class speakers ...
» more

PRESS RELEASE: 21 September 2009
Geistlich Pharma AG occupies new premises
A sign of growth and investment in Central Switzerland ...
» more

15 September 2009
Great interest in Geistlich Pharma AG at its Open Door Day
On 12.09.09, to mark the inauguration of the new office building Z5, Geistlich Pharma AG opened up to the public its new premises ...
» more

10 September 2009
A warm welcome to Geistlich Pharma AG!
On 12 September, Geistlich Pharma AG is giving the public a glimpse behind the scenes of its future new place of work ...
» more

24. Juni 2009
Europerio, Stockholm – Geistlich Pharma on target
Geistlich Pharma AG showcased its business unit Geistlich Biomaterials at the 6th Europerio in Stockholm ...
» more

16. April 2009
IDS in Cologne 2009: Geistlich at Europe's biggest dental fair
With a prominent booth Geistlich Biomaterials took part in the 33rd International Dental Show (IDS) in Cologne from March 24th to 28th....
» more

06. March 2009
Geistlich passes FDA inspection for the 5th time
In February 2009, Geistlich Pharma has fully passed the FDA-inspection. For the fifth time the company meets the strict criteria of the US Food and Drug Administration (FDA)....
» more

05. March 2009
More room for quality
At the end of 2008 the Quality Assurance (QA) and Facility Maintenance & Development departments of Geistlich Pharma AG moved into their new premises...
» more

  © Geistlich Pharma AG
 Print page Recommend page Imprint Disclaimer Top